SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-16-012558
Filing Date
2016-02-10
Accepted
2016-02-10 08:31:22
Documents
4
Period of Report
2016-02-10
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kmph-8k_20160210.htm 8-K 39870
2 EX-99.1 kmph-ex991_6.htm EX-99.1 19713
3 GRAPHIC g201602101309523483162.jpg GRAPHIC 3070
4 GRAPHIC g201602101309523323161.jpg GRAPHIC 1727
  Complete submission text file 0001564590-16-012558.txt   67727
Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 161402241
SIC: 2834 Pharmaceutical Preparations